Status:
COMPLETED
Facilitating Web-based Patient Decision Support: Decision About Medication to Lower Breast Cancer Risk
Lead Sponsor:
National Cancer Institute (NCI)
Conditions:
High Risk for Breast Cancer
Risk Reduction Behavior
Eligibility:
FEMALE
35-100 years
Phase:
NA
Brief Summary
Background: * Chemoprevention is the use of preventive medications to reduce the risk of breast cancer for women who are at a high risk of developing the disease. Although the treatment has shown eff...
Detailed Description
BACKGROUND: * Breast cancer chemoprevention has been notably underutilized. * Barriers to integrating breast cancer risk reducing measures include: lack of time, low priority of risk reduction in com...
Eligibility Criteria
Inclusion
- INCLUSION CRITERIA:
- Women with no history of cancer other than cervical carcinoma in situ or non-melanoma skin cancer
- High risk for breast cancer based on at least one of the following:
- Gail score \> 1.67
- History of atypical hyperplasia (either ductal or lobular)
- History of lobular carcinoma in situ
- Documentation of a deleterious BRCA1 or BRCA2 mutation
- Considering a decision about chemoprevention with tamoxifen or raloxifene
- Access to an IBM-compatible or MacIntosh personal computer with broadband Internet access
- Access to an email account
- Access to a telephone
- Aged 35 or older
- Able to communicate in English verbally and in writing
- Women of all races and ethnic groups are eligible for this study.
- EXCLUSION CRITERIA:
- Concurrent participation in another cancer chemoprevention study
- Prior history of cancer, other than cervical carcinoma in situ or non-melanoma skin cancer
- Ever taken tamoxifen or raloxifene
- Age less than 35
- Unable to communicate in English verbally and in writing
- No computer with internet access
- No email account
- No telephone
Exclusion
Key Trial Info
Start Date :
May 18 2009
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 26 2010
Estimated Enrollment :
64 Patients enrolled
Trial Details
Trial ID
NCT00906321
Start Date
May 18 2009
End Date
May 26 2010
Last Update
July 2 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Cancer Institute (NCI), 9000 Rockville Pike
Bethesda, Maryland, United States, 20892